CHRISTINA BELLINA: Open Payments
NPI 1336674423 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,262 in 125 payments from 21 companies in 2025. Trend: 2023 $1,000 · 2024 $1,993 · 2025 $3,262
Food & beverage: $3,138Education: $125
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $742 |
| GlaxoSmithKline, LLC. | 30 | $597 |
| Actelion Pharmaceuticals US, Inc. | 9 | $297 |
| GENZYME CORPORATION | 9 | $241 |
| Regeneron Healthcare Solutions, Inc. | 13 | $227 |
| United Therapeutics Corporation | 7 | $210 |
| Insmed, Inc. | 10 | $206 |
| Merck Sharp & Dohme LLC | 4 | $148 |
| Verona Pharma, Inc. | 3 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $104 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, FASENRA, OPSUMIT, Tyvaso, Arikayce, WINREVAIR.
Industry payments across NC — which companies pay providers there.
